Identification of Novel Regulators of LINE-1 Expression via CRISPR/Cas9 Screening
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 4 × HCT116-Cas9 no reporter vs 4 × HCT116-Cas9 L1 WT reporter vs 4 × HCT116-Cas9 L1 EN/RT MT reporterGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Identification of novel regulators of LINE-1 expression via CRISPR/Cas9 screeningMobile DNA · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE313499_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1379653 and SRA study SRP654579. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 3 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9369017 HCT116-Cas9 no reporter - Replicate-1 HCT116-Cas9 no reporter
- GSM9369018 HCT116-Cas9 no reporter - Replicate-2 HCT116-Cas9 no reporter
- GSM9369019 HCT116-Cas9 no reporter - Replicate-3 HCT116-Cas9 no reporter
- GSM9369020 HCT116-Cas9 no reporter - Replicate-4 HCT116-Cas9 no reporter
- GSM9369021 HCT116-Cas9 L1 WT reporter - Replicate-1 HCT116-Cas9 L1 WT repor…
- GSM9369022 HCT116-Cas9 L1 WT reporter - Replicate-2 HCT116-Cas9 L1 WT repor…
- GSM9369023 HCT116-Cas9 L1 WT reporter - Replicate-3 HCT116-Cas9 L1 WT repor…
- GSM9369024 HCT116-Cas9 L1 WT reporter - Replicate-4 HCT116-Cas9 L1 WT repor…
- GSM9369025 HCT116-Cas9 L1 EN/RT MT reporter - Replicate-1 HCT116-Cas9 L1 EN/RT MT…
- GSM9369026 HCT116-Cas9 L1 EN/RT MT reporter - Replicate-2 HCT116-Cas9 L1 EN/RT MT…
- GSM9369027 HCT116-Cas9 L1 EN/RT MT reporter - Replicate-3 HCT116-Cas9 L1 EN/RT MT…
- GSM9369028 HCT116-Cas9 L1 EN/RT MT reporter - Replicate-4 HCT116-Cas9 L1 EN/RT MT…
- GSE301632 Genome-wide CRISPR-Cas9 knockout screening identifies NUDCD2 depletion as sensitizer for bortezomib, carfilzomib and ixazomib in multiple myeloma. 27 samples shares crispr, cas9, screening
- GSE303100 Dissecting Resistance to CDK4/6 Inhibition in Experimental Glioma via Genome-wide CRISPR-Cas9 Screening 24 samples shares crispr, cas9, screening
- GSE310675 CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer 12 samples shares crispr, cas9, screening
- GSE276052 CRISPR screening identifies regulators of enhancer mediated androgen receptor transcription in advanced prostate cancer 92 samples shares crispr, regulators, screening
- GSE293514 Development of a split-toxin CRISPR screening platform to systematically identify upstream regulators of human myoblast fusion 57 samples shares crispr, regulators, screening
- GSE275927 CRISPR screening identifies regulators of enhancer mediated androgen receptor transcription in advanced prostate cancer (ATAC-Seq) 8 samples shares crispr, regulators, screening
- GSE290621 Quadruple adenine base edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease engineered T cells [RNA-seq] 33 samples shares crispr, cas9
- GSE240468 Silencing of NFYC-AS1 by Gapmer antisense oligonucleotides and CRISPR/Cas9 TSS deletion. 23 samples shares crispr, cas9
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.